Limitations and Opportunities in Topical Drug Delivery: Interaction Between Silica Nanoparticles and Skin Barrier

被引:19
作者
Arriagada, Francisco [1 ]
Morales, Javier [1 ]
机构
[1] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile
关键词
Silica nanoparticles; skin delivery; topical delivery; nanomedicines; skin disorders; nanocarriers; FILM-FORMING FORMULATIONS; CANCER-TARGETED PROBES; MESOPOROUS SILICA; SURFACE FUNCTIONALIZATION; LIPID NANOPARTICLES; TRANSDERMAL ROUTE; POROUS SILICA; IN-VITRO; PENETRATION; METHOTREXATE;
D O I
10.2174/1381612825666190404121507
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The first limiting barrier for the transport in the skin is the stratum corneum; different strategies have been developed to overcome this barrier, including chemical enhancers. However, these penetration enhancers have limitations, including toxic adverse effects. In this context, research into nanomaterials has provided new tools to increase the residence time of drugs by generating a reservoir, increasing the specificity of drugs and reducing their adverse effects, and improving the penetration of drugs that are difficult to formulate. Silica nanoparticles have been proposed as suitable nanocarriers for skin delivery. Unfortunately, the mechanisms involved in the interaction, transport and fate of silica nanoparticles in the skin have not been fully investigated. This paper reviews significant findings about the interaction between silica-based nanocarriers and the skin. First, this review focuses on the properties and functions of the skin, the skin penetration properties of silica nanoparticles, their synthesis strategies and their toxicity. Finally, advances and evidence on the application of silica nanocarriers in skin drug delivery are provided, in which the use of nanoparticles increases the stability and solubility of the bioactive compound, enhancing its performance, act as penetrator enhancer and improving controlled release. Thus, improving the treatment of some skin disorders.
引用
收藏
页码:455 / 466
页数:12
相关论文
共 140 条
[1]   Approaches for breaking the barriers of drug permeation through transdermal drug delivery [J].
Alexander, Amit ;
Dwivedi, Shubhangi ;
Ajazuddin ;
Giri, Tapan K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Tripathi, Dulal Krishna .
JOURNAL OF CONTROLLED RELEASE, 2012, 164 (01) :26-40
[2]  
[Anonymous], 51 JACC
[3]   Extracellular matrix as a biological scaffold material: Structure and function [J].
Badylak, Stephen F. ;
Freytes, Donald O. ;
Gilbert, Thomas W. .
ACTA BIOMATERIALIA, 2009, 5 (01) :1-13
[4]   Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding [J].
Bagwe, RP ;
Hilliard, LR ;
Tan, WH .
LANGMUIR, 2006, 22 (09) :4357-4362
[5]  
Bainbridge P, 2013, J WOUND CARE, V22, P407
[6]   PERCUTANEOUS-ABSORPTION OF METHOTREXATE - EFFECT ON EPIDERMAL DNA-SYNTHESIS IN HAIRLESS MICE [J].
BALL, MA ;
MCCULLOUGH, JL ;
WEINSTEIN, GD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (01) :7-10
[8]   Drug delivery routes in skin: a novel approach [J].
Barry, BW .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 :S31-S40
[9]   Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma [J].
Benezra, Miriam ;
Penate-Medina, Oula ;
Zanzonico, Pat B. ;
Schaer, David ;
Ow, Hooisweng ;
Burns, Andrew ;
DeStanchina, Elisa ;
Longo, Valerie ;
Herz, Erik ;
Iyer, Srikant ;
Wolchok, Jedd ;
Larson, Steven M. ;
Wiesner, Ulrich ;
Bradbury, Michelle S. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2768-2780
[10]  
Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915